Business Segments Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 285.94 USD | -2.22% |
|
-2.85% | -5.63% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Clinical Diagnostics | 151.59Cr | 145.1Cr | 148.93Cr | 153.79Cr | 156.21Cr | |||||
Total Assets | 103.84Cr | 45Cr | 49Cr | 47Cr | 45Cr | |||||
Interest Expense | -10L | - | - | - | - | |||||
CAPEX | -6.35Cr | - | - | - | - | |||||
EBT | 17Cr | - | - | - | - | |||||
Gross Profit | - | - | - | 80Cr | 79Cr | |||||
D&A | 6.11Cr | 7.94Cr | 8.31Cr | 8.43Cr | 9.04Cr | |||||
Operating Income | - | 22Cr | 23Cr | - | - | |||||
Life Sciences Tools and Services | ||||||||||
Life Science | 140.08Cr | 134.72Cr | 117.84Cr | 102.81Cr | 102.11Cr | |||||
Total Assets | 59Cr | 27Cr | 29Cr | 29Cr | 29Cr | |||||
Interest Expense | -6L | - | - | - | - | |||||
CAPEX | -1.28Cr | - | - | - | - | |||||
EBT | 32Cr | - | - | - | - | |||||
Gross Profit | - | - | - | 58Cr | 55Cr | |||||
D&A | 3.25Cr | 5.79Cr | 6.28Cr | 6.73Cr | 7.5Cr | |||||
Operating Income | - | 27Cr | 11Cr | - | - | |||||
Other Operations | 58L | 40L | 36L | 5L | - | |||||
Total Assets | 1.68Cr | 6L | 3L | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
CAPEX | -76L | - | - | - | - | |||||
EBT | -11L | - | - | - | - | |||||
Gross Profit | - | - | - | -1L | - | |||||
D&A | 16L | - | - | - | - | |||||
Operating Income | - | -19L | -7L | - | - | |||||
EBT | 492.62Cr | - | - | - | - | |||||
Total Assets | 35Cr | - | - | 41Cr | 58Cr | |||||
Total Assets | 1.47TCr | - | - | 523.47Cr | 638.06Cr | |||||
Total Assets | 4.82Cr | - | - | 69Cr | 71Cr | |||||
Total Assets | 99Cr | - | - | 227.03Cr | 216.55Cr | |||||
EBT | 2.68Cr | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | -28L | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 113.06Cr | 115.55Cr | 112.19Cr | 104.15Cr | 102.27Cr | |||||
Total Assets | 46Cr | 47Cr | 48Cr | 46Cr | 47Cr | |||||
Europe | 95Cr | 85Cr | 82Cr | 83Cr | 88Cr | |||||
Total Assets | 21Cr | 18Cr | 20Cr | 17Cr | 19Cr | |||||
Asia | 69Cr | 64Cr | 56Cr | 52Cr | 51Cr | |||||
Total Assets | 6.49Cr | 6.38Cr | 8.27Cr | 9.71Cr | 9.33Cr | |||||
Other (primarily Canada and Latin America) | 16Cr | 16Cr | 17Cr | 17Cr | 17Cr | |||||
Total Assets | 1.65Cr | 1.56Cr | 1.91Cr | 1.41Cr | 1.67Cr | |||||
Pacific Rim | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Stocks
- BIO Stock
- Financials Bio-Rad Laboratories, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
